NMRA vs TSLA · $283.5M cap vs P/E 179, rev $94.83B
Neumora Therapeutics, Inc. (NMRA) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
NMRA does not have a complete income-statement cache yet.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
NMRA currently screens at market cap $283.5M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the NMRA and TSLA stock pages for the full models.
Not investment advice.